- Brand Name : Invanz
- Drug Class : Carbapenems
- Medical Author : Sarfaroj Khan, BHMS, PGD Health Operations
- Medical Reviewer :
- _eael_post_view_count : 7
What Is Ertapenem and How Does It Work?
Ertapenem is a prescription medication used to treat the symptoms of Community-Acquired Pneumonia, Complicated urinary Tract Infections (including Pyelonephritis), Acute Pelvic Infections, Complicated Intra-abdominal Infections, and Complicated Skin or Skin Structure Infections.
- Ertapenem is available under the following different brand names: Invanz
What Are Dosages of Ertapenem?
Adult and Pediatric dosage
Powder for injection
- 1g/vial
Community-Acquired Pneumonia
Adult dosage:
- 1 g/day IV/IM up to 14 days; after 3 or more days of parenteral therapy, may be switched to appropriate oral regimen if patient improves clinically
Pediatric dosage
- Children younger than 3 months of age: safety and efficacy not established
- Children 3 months-12 years: 15 mg/kg IV/IM every 12 hours up to 14 days; not to exceed 1g every 12 hours; after 3 or more days of parenteral therapy, may be switched to appropriate oral regimen if patient improves clinically
- Children older than 12 years of age: 1 g/day IV/IM up to 14 days; after 3 or more days of parenteral therapy, may be switched to appropriate oral regimen if patient improves clinically
Complicated Urinary Tract Infections (Including Pyelonephritis)
Adult dosage
- 1 g/day IV/IM up to 14 days; after 3 or more days of parenteral therapy, may be switched to appropriate oral regimen if patient improves clinically
Pediatric dosage
- Children younger than 3 months of age: safety and efficacy not established
- Children 3 months-12 years: 15 mg/kg IV/IM every 12 hours up to 14 days; not to exceed 1g every 12 hours; after 3 or more days of parenteral therapy, may be switched to appropriate oral regimen if patient improves clinically
- Children older than 12 years of age: 1 g/day IV/IM up to 14 days; after 3 or more days of parenteral therapy, may be switched to appropriate oral regimen if patient improves clinically
Acute Pelvic Infections
Adult dosage
- 1 g/day IV/IM for 3-10 days
Pediatric dosage
- Children younger than 3 months of age: safety and efficacy not established
- Children 3 months-12 years: 15 mg/kg IV/IM every 12 hours for 3-10 days
- Children older than 12 years of age: 1 g/day IV/IM for 3-10 days
Complicated Intra-abdominal Infections
Adult dosage
- 1 g/day IV/IM for 5-14 days
Pediatric dosage
- Children younger than 3 months of age: safety and efficacy not established
- Children 3 months-12 years: 15 mg/kg IV/IM every 12 hours for 5-14 days
- Children older than 12 years of age: 1 g/day IV/IM for 5-14 days
Complicated Skin/Skin Structure Infections
Adult dosage
- 1 g/day IV/IM for 7-14 days; may be continued up to 4 weeks for diabetic foot infections, depending on severity of infection and response to therapy and response to therapy (treatment excludes diabetic foot infections with osteomyelitis)
Pediatric dosage
- Children younger than 3 months of age: safety and efficacy not established
- Children 3 months-12 years: 15 mg/kg IV/IM every 12 hours for 7-14 days; may be continued up to 4 weeks for diabetic foot infections, depending on severity of infection and response to therapy (treatment excludes diabetic foot infection with osteomyelitis)
- Children older than 12 years of age: 1 g/day IV/IM up to 7-14 days; may be continued up to 4 weeks for diabetic foot infections, depending on severity of infection and response to therapy (treatment excludes diabetic foot infections with osteomyelitis)
Dosage Considerations – Should be Given as Follows:
- See “Dosages.”